$DRRX HTX-011 investigators appears 'not to' be very honest. Many unknowns. So I am not sure it will be a slam dunk. Remember Dr.Simon said .It is better to be very honest,transparent and give all data to the FDA with clear presentation and he addressed each issues raised in the CRL.But again my take is the chance of both HTX011 nd Posimir are 50/50. Besides there is a new team in the department and will scrutinize again all the data. FDA does not care.. Read this article below. avanospainmanagement.com/wp...
  • 3
3 Likes